Table 3 -.

Outcomes through 30 days

Outcome	n=12	Relatedness to TCD*
Post-TAVR hospital length of stay	2 (2,8)	—
Death
Cardiovascular	0	—
Non-cardiovascular	1	Unrelated
Stroke	2	Unrelated
Myocardial infarction	1	Unrelated
Acute kidney injury (stage II or III)	0	—
Transfusion	1 (1 unit)	Unrelated
VARC-2 bleeding
Life-threatening	0	—
Major	1	Unrelated
VARC-2 vascular complications
Major	0	—
Minor	2	1 unrelated / 1 possibly related

VARC-2: Second valve academic research consortium consensus.

^*relatedness of event to the TCD device adjudicated by independent clinical events adjudication committee